- VIVUS Reports First Quarter 2015 Financial Results
- VIVUS Announces Date of First Quarter 2015 Update and Financial Results Conference Call
- VIVUS Announces New Discount Program Through Sam's Club for Qsymia Patients
- VIVUS Announces Issuance of Two Additional U.S. Patents for Qsymia
- VIVUS Files Lawsuit Against Teva for Infringement of Qsymia Patents
Latest EventsThere are currently no upcoming events
A Growing Pipeline
VIVUS is developing innovative, next-generation therapies to address unmet needs in obesity, diabetes, sleep apnea and sexual health.